Results

Total Results: 1,077 records

Showing results for "phase".

261. Disposition of Comments Report for Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_disposition-comments.pdf
     January 01, 2010 - Further, small studies [Phase I (safety); Phase II (dose- ranging; mechanistic)] may show effects which … cannot, and are not reproduced in larger field trials (Phase IIB/Phase III), and hence never get … Results This next clinical trial was designed based on what had been learned from this initial Phase … However, this subsequent Phase IIB/III clinical study, of 400+ ragweed-allergic patients with RCS,

262. AHRQ Researchers Show How Learning Health Systems Can Help Organizations Improve Practice | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/news/health-systems-journal-article
     December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

263. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Results The table below lists the four topics for which (1) preliminary phase III data for drugs, phase … In September 2015, ITCA 650’s manufacturer announced study results from the phase III FREEDOM-1 and … In phase III clinical trials, the device is intended to deliver a dose of 40 or 60 mcg of exenatide … Available: http://www.intarcia.com/media/press- releases/2014-oct-1-phase-3.html. 10. … Intarcia announces presentations at ADA of two successful freedom phase 3 trials for ITCA 650 - a

264. Systematic Review Search Strategy Development Tools: A Practical Guide for Expert Searchers | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/search-strategy/white-paper
     February 01, 2025 - quick and intuitive guide for expert searchers that organizes the tools by search strategy development phase

265. FRN 22: Future Research Needs for Strategies To Reduce Cesarean Birth in Low-Risk Women (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cesarean-birth_research.pdf
     January 01, 2020 - In Phase 1, stakeholders generated a “snowballed” list of 47 research questions and 17 methodologic … In Phase 2, stakeholders worked from the snowballed list to prioritize research needs. … Stakeholder participation at each phase of the prioritization process In phase 1, the EPC investigators … Figure 5 shows the snowballing process and results for Phase 1. Figure 5. … During the prioritization phase, stakeholders raised a number of issues.

266. Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
     February 07, 2018 - contextual question (CQ) were posted for public comment in August 2017 prior to the topic refinement phase … Single Blind Method/ 51. clinical trial/ 52. clinical trial, phase i.pt. 53. clinical trial … , phase ii.pt. 54. clinical trial, phase iii.pt. 55. clinical trial, phase iv.pt. 56. controlled

267. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
     January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

268. Topic 0614 Tonsillectomy NSD FINAL CC (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0768-141211.pdf
     October 23, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

269. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0262_05-11-2007.pdf
     January 01, 2007 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

270. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the four topics for which (1) preliminary phase III data for drugs and … biologics or phase II data for devices and procedures were available; (2) information was compiled … Phase III trials reported that patients with SBS treated with teduglutide can significantly reduce … day) once daily.31 Clinical trials: In results of a randomized, double-blind, placebo-controlled, phase

271. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - Results The table below lists the six topics for which (1) preliminary phase III data for drugs, at … least phase II or equivalent data for devices and procedures, or some human data for off-label uses … In March 2013, Intarcia began phase III trials of the ITCA 650/pump system. … Two phase II clinical trials have been completed.83 Intarcia has announced enrollment in its phase … Intarcia CEO to present company progress, interim phase 3 data, and key milestones at J.P.

272. Comparative Effectiveness of Treatments for Cryptorchidism | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/undescended-testicle/research-protocol
     December 01, 2019 - We received no comments during the public posting phase on the KQs or analytic framework. … No comments related to the framework were received during the public posting phase. Figure 1. … Review – Table 1 lists the inclusion and exclusion criteria developed during the topic refinement phase … predetermined inclusion/exclusion criteria or for which we have insufficient information at the abstract phase

273. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … tracked topics in this area have matured sufficiently to enable development of profiles with late-phase

274. White Paper_Living Systematic Reviews: Examining Excluded Full-Text Articles To Better Understand the Evidence Base on Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/living-systematic-reviews-full-text-articles-white-paper.pdf
     January 01, 2024 - A phase 2 randomised clinical trial assessing the tolerability of two different ratios of medicinal … Olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, in a Phase … pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase … inclusion criteria (psilocybin), cluster headaches not chronic pain Yes Schloss, J.65 2021 A phase … A phase 2 randomised clinical trial assessing the tolerability of two different ratios of medicinal

275. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the single topic for which (1) preliminary mid- to late-phase clinical

276. Long-Term Care for Older Adults: A Comparative Effectiveness Review of Institutional versus Home and Community-based Care | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/long-term-care-adults/research-protocol
     December 01, 2019 - method/ (113493) 31 single blind method/ (15658) 32 clinical trial/ (469154) 33 clinical trial, phase … i.pt. (11784) 34 clinical trial, phase ii.pt. (18612) 35 clinical trial, phase iii.pt. (6631) … 36 clinical trial, phase iv.pt. (654) 37 controlled clinical trial.pt. (83741) 38 randomized controlled

277. Llewellyn-Thomas (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/llewellyn-thomas.pdf
     January 01, 2011 - Patient-­‐Clinician/Decision Coach  Transaction • Narrower Perspective — In the V/P Elicitation Phase … Slide  31: In the  V/P Elicitation Phase  of Decision Support TO TEACH V/P  ELICITATION AS A

278. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
     September 02, 2011 - We received no comments during the public posting phase on the KQs or analytic framework. 3 … No comments related to the framework were received during the public posting phase. … Review – Table 1 lists the inclusion and exclusion criteria developed during the topic refinement phase … predetermined inclusion/exclusion criteria or for which we have insufficient information at the abstract phase

279. Assessing the Impact of Indexing Performance Measure Codes on the Perceived Value of EPC Reports to Health Systems (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-assessing-impact.pdf
     September 01, 2018 - Evaluation Methods In the first phase, we asked the key informants from Duke University Health System … In the second phase, we sent the enhanced EPC draft report on urinary incontinence with brief written … Results Final Product Description After the first phase feedback from the key informants at Duke University … Evaluation Results In the phase one assessment, the key informants from the Duke University Health System … In the phase two assessment, we used the two exercise scenarios and three query questions described

280. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
     January 01, 2012 - inclusion are those interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase … III trials for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or … phase II data for procedures were available; (2) information was compiled by November 2011 in this … European Medicines Agency. 21,27 In results of a randomized, double blind, placebo-controlled, phase